Cargando…
APP in the Neuromuscular Junction for the Development of Sarcopenia and Alzheimer’s Disease
Sarcopenia, an illness condition usually characterized by a loss of skeletal muscle mass and muscle strength or function, is often associated with neurodegenerative diseases, such as Alzheimer’s disease (AD), a common type of dementia, leading to memory loss and other cognitive impairment. However,...
Autores principales: | Wu, Min-Yi, Zou, Wen-Jun, Lee, Daehoon, Mei, Lin, Xiong, Wen-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178513/ https://www.ncbi.nlm.nih.gov/pubmed/37175515 http://dx.doi.org/10.3390/ijms24097809 |
Ejemplares similares
-
Muscular Swedish mutant APP-to-Brain axis in the development of Alzheimer’s disease
por: Pan, Jin-Xiu, et al.
Publicado: (2022) -
Motoneuron Wnts regulate neuromuscular junction development
por: Shen, Chengyong, et al.
Publicado: (2018) -
APP interacts with LRP4 and agrin to coordinate the development of the neuromuscular junction in mice
por: Choi, Hong Y, et al.
Publicado: (2013) -
The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia
por: Ham, Daniel J., et al.
Publicado: (2020) -
Lactate Metabolism, Signaling, and Function in Brain Development, Synaptic Plasticity, Angiogenesis, and Neurodegenerative Diseases
por: Wu, Anika, et al.
Publicado: (2023)